Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade
- 1 February 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 57 (5), 601-611
- https://doi.org/10.1016/j.jacc.2010.09.037
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (LA 1432/3-1)
- Berlin Chemie
- Swiss National Research Grant (310030-122339)
- Zurich Center for Integrative Human Physiology
- Fondation Leducq
This publication has 47 references indexed in Scilit:
- β3-Adrenoceptor Stimulation on Top of β1-Adrenoceptor Blockade: “Stop or Encore?”Journal of the American College of Cardiology, 2009
- Nebivolol Reduces Nitroxidative Stress and Restores Nitric Oxide Bioavailability in Endothelium of Black AmericansCirculation, 2005
- Endothelial β 3 -Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent HyperpolarizationCirculation, 2004
- Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of CardiologyEuropean Heart Journal, 2004
- Estrogen Receptor-Mediated Vascular Responsiveness to Nebivolol: A Novel Endothelium-Related Mechanism of Therapeutic VasorelaxationJournal of Cardiovascular Pharmacology, 2004
- Involvement of the β3 Adrenoceptor in Nebivolol-Induced Vasorelaxation in the Rat AortaJournal of Cardiovascular Pharmacology, 2003
- Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Nebivolol Reverses Endothelial Dysfunction in Essential HypertensionCirculation, 2001
- Nebivolol decreases systemic oxidative stress in healthy volunteersBritish Journal of Clinical Pharmacology, 2000
- Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide ReleaseCirculation, 2000